ABSTRACT
The COVID-19 pandemic became a challenge to maintain care for patients with idiopathic intracranial hypertension (IIH). We aimed to find out how they were affected during lockdown. Thirty IIH patients admitted to hospital during the COVID-19 pandemic were studied. Their demographic and neuro-ophthalmological findings were evaluated. The World Health Organization – Five Well-Being Index (WHO-5), the EUROHIS Quality of Life (QOL) 8-item index, National Eye Institute Visual Functioning Questionnaire (NEI-VFQ-25), Headache Impact Test (HIT-6), and COVID-19 Fear Scale were used to assess QOL and pandemic-associated fear. Thirty age, sex, and body mass index matched volunteers constituted the control group. Apart from the COVID-19 Fear Scale and colour vision subscale of the NEI-VFQ-25, all scale scores were worse in IIH patients than in healthy control subjects. Patients with severe visual field defects had higher HIT-6 scores (p = .036). Both vision-specific and overall QOL was reduced in patients with IIH. Headache severity and disability were more prominent in patients with severe visual loss. Fear caused by the COVID pandemic was not different in IIH patients than in healthy control subjects.
Acknowledgments
The authors would like to thank Atilla Atasever for his contribution to the statistical analysis.
Data availability statement
All data generated or analysed during this study are included in this published article.
Declaration of interest statement
No potential conflict of interest was reported by the authors.
Patient consent and ethics statement
A written informed consent was obtained from all participants. The study protocol was approved by Ege University Medical School Ethics Committee and Turkish Ministry of Health (reference number: 99166796-050.06.04782) and was performed in accordance with the ethical standards outlined in the Declaration of Helsinki.